Stockholm Fashion District Hosts Fashion Week Trade Where Swedish Initiatives Are Paving the Way for a Bright New Future
14.8.2024 15:33:00 EEST | Business Wire | Press release
Stockholm Fashion District is revolutionizing the fashion industry by offering a vibrant platform for designers, creatives and buyers to connect. Unlike traditional trade platforms that occur just twice a year, Stockholm Fashion District hosts multiple trade shows annually - pushing the boundaries of industry conventions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240813925340/en/
Catwalk on the Grand Opening of Fashion Week Trade, 12-16 August 2024 (Photo: Business Wire)
This innovative approach allows creatives in the industry to connect, inspire and gain valuable market exposure, all under the same roof.
"The fashion industry is ever changing, therefore initiatives in trade conventions are crucial to reflect the current landscape and its eager pioneers" says Helena Walker, CEO Stockholm Fashion District
During this Fashion Week Trade, 12-16 August, Stockholm Fashion District opens its doors to one of the biggest trade events of the year. By incorporating 700 fashion brands, ranging from mid-market to premium, the event seamlessly blends different brands showcasing fashion, shoes and accessories.
With its purpose of bringing people together, the event will celebrate creativity and innovation by having fashion enthusiasts and professionals attending from all around the world. Relationships and businesses will grow.
"The world around us is definitely very challenging for our industry. Cooperation, flexibility, and transition are the way to the future, and we are a reliable player and meeting place for the industry. Together we create energy to find new opportunities." says Helena Walker, CEO Stockholm Fashion District
The fashion industry in Sweden is a significant contributor to the country's economy, generating a revenue of 173 billion SEK and employing around 40,000 people. Sweden is known for its emphasis on innovation, entrepreneurship, sustainability, and creativity - values that are reflected in the fashion industry.
Beyond the conventional twice-a-year fashion trade convention, Stockholm Fashion District is providing a year-round platform for designers, creatives and buyers to connect. Linking Swedish fashion enterprises to the global market, the area hosts 22 yearly sales-focused events in addition to its 143 showrooms that are open year-round. Along with collaborative opportunities and training sessions, Trade Partners Sweden supports with legal, logistical, and sales expertise. The organization supports fashion professionals all year round.
Fashion Week Trade is taking place between 12–16 August in Stockholm
Link to the program here
Link to the brand list here
For more information about the Swedish fashion industry, read the Fashion Transformation Report here.
ABOUT:
Stockholm Fashion District (SFD)
https://www.stockholmfash iondistrict.se
Trade Partners Sweden (TPS)
https://www.tradepartnerssweden.se/
Trade Partners Sweden is a member organization representing Swedish agents, suppliers, and distributors in fashion, shoes, and textiles. They are the founders of Stockholm Fashion District, a company that serves as the physical meeting place for the industry in Sweden and hosts events including Fashion Week Trade.
PRESS IMAGES:
Click here
View source version on businesswire.com: https://www.businesswire.com/news/home/20240813925340/en/
Contacts
PRESS CONTACT:
Linda Ekstrom, Head of Marketing & Communications
linda.ekstrom@tradepartners.se, - linda.ekstrom@tradepartners.se +46 73 525 99
53
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom